<DOC>
	<DOCNO>NCT01430884</DOCNO>
	<brief_summary>During elective percutaneous coronary intervention ( PCI ) , proximal distal protection device use . The distal occlusion protection device temporarily occlude vessel distal lesion intervention , thereby capture particular debris soluble substance release lesion aspirate prevent reach coronary microcirculation . Rather simply discard material retrieve use protection device , investigator recently take advantage situation , sample particulate soluble material subject variety analysis ultimate goal well insight respective plaque composition correlate individual image clinical data . On basis information investigator aim good understand pathophysiology plaque vulnerability possibly predict clinical development individual patient .</brief_summary>
	<brief_title>Analysis Human Coronary Aspirate</brief_title>
	<detailed_description>Patients - Symptomatic patient significant stenosis ( diameter stenosis &gt; 75 % significant FFR ) native coronary vessel saphenous vein aortocoronary bypass graft . - All patient aspirin ( 100 mg/day ) receive 10,000 I.U . heparin intravenously . - Coronary angiography perform via femoral approach . - Full informed consent obtain patient participate study . Stenosis severity/Plaque composition - Quantification stenosis severity perform use off-line caliper measurement ( QCA-MEDIS , Leiden , NL ) . - Intravascular imaging analysis stent implantation characterize plaque morphology : 1 . IVUS ( Eagle-EyeTM 20 MHz catheter R-100 pullback device , Volcano Corporation , Rancho Cordova , CA , USA ) 2 . OCT ( St. Jude Medical Lightlab C7 Dragonfly Imaging Catheter ) 3 . NIRS ( InfraReDx TVC Insight catheter ) Interventional procedure Distal balloon occlusion device : - TriAktiv SVG/3.5-FX-catheter ; Kensey Nash , Exton , USA - GuardWire Temporary Occlusion &amp; Aspiration System ; Medtronic Inc. , Minneapolis , MN USA Implantation balloon-expandable stent use balloon pressure 14 18 atm balloon-to-vessel diameter ratio 1:1 . Coronary arterial blood coronary aspirate - Coronary arterial blood take distal lesion stent implantation coronary aspirate blood obtain stent implantation ( Heparin- EDTA- Monovettes , SARSTEDT AG &amp; Co , Nümbrecht , Germany ) . - Ex vivo coronary aspirate blood filter mesh filter pore 40 μm diameter . - Immediately centrifugation filter coronary arterial aspirate blood ( 800g , 10 min , 4°C ) . - Particulate debris coronary arterial aspirate plasma quickly freeze liquid nitrogen store -80°C use . Analysis / Aim : - Using different method determine severity stenosis plaque composition . - Using different biochemical method characterize particular soluble substance release stenting coronary aspirate . - Using different bioassay study vasoconstrictor potential human coronary aspirate plasma impact . coronary aspirate coronary microcirculation cardiac contraction . - Correlation ex vivo measurement patient disease clinical symptom .</detailed_description>
	<mesh_term>Heart Diseases</mesh_term>
	<mesh_term>Coronary Disease</mesh_term>
	<mesh_term>Coronary Artery Disease</mesh_term>
	<mesh_term>Myocardial Ischemia</mesh_term>
	<mesh_term>Arteriosclerosis</mesh_term>
	<mesh_term>No-Reflow Phenomenon</mesh_term>
	<criteria>Symptomatic patient significant stenosis ( diameter stenosis &gt; 75 % significant FFR ) native coronary vessel saphenous vein aortocoronary bypass graft Patients whereby distal balloon occlusion device applicable</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2014</verification_date>
	<keyword>coronary aspirate blood</keyword>
	<keyword>particular debris / microemboli</keyword>
	<keyword>distal occlusion device</keyword>
</DOC>